Search Results - "Tordo, Julie"
-
1
Division-Coupled Astrocytic Differentiation and Age-Related Depletion of Neural Stem Cells in the Adult Hippocampus
Published in Cell stem cell (06-05-2011)“…Production of new neurons in the adult hippocampus decreases with age; this decline may underlie age-related cognitive impairment. Here we show that continuous…”
Get full text
Journal Article -
2
Inhibition of somatosensory mechanotransduction by annexin A6
Published in Science signaling (19-06-2018)“…Mechanically activated, slowly adapting currents in sensory neurons have been linked to noxious mechanosensation. The conotoxin NMB-1 (noxious mechanosensation…”
Get more information
Journal Article -
3
The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
Published in Molecular therapy. Nucleic acids (01-06-2012)“…Many genetic diseases are induced by mutations disturbing the maturation of pre-mRNAs, often affecting splicing. Antisense oligoribonucleotides (AONs) have…”
Get full text
Journal Article -
4
A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency
Published in Brain (London, England : 1878) (01-07-2018)“…Tordo et al. present a novel AAV gene therapy vector, AAV-TT, which exceeds the current benchmark neurotropic serotypes AAV9 and AAVrh10 and enables…”
Get full text
Journal Article -
5
AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease
Published in Human molecular genetics (01-09-2018)“…Abstract Niemann-Pick type C disease (NP-C) is a fatal neurodegenerative lysosomal storage disorder. It is caused in 95% of cases by a mutation in the NPC1…”
Get full text
Journal Article -
6
Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2
Published in Journal of structural biology (01-12-2021)“…[Display omitted] •Structurally, the VP topology and capsid morphology of AAV-TT is homologous to AAV2.•AAV-TT differs by 14 amino acids from AAV2, two of…”
Get full text
Journal Article -
7
Gene therapy mediated correction of neurological manifestations of MPS IIIC using a novel AAV serotype
Published in Molecular genetics and metabolism (01-01-2017)Get full text
Journal Article -
8
256. A Novel Rationally Designed AAV Capsid Yields a Potent Neurotropic Gene Therapy Vector
Published in Molecular therapy (01-05-2016)Get full text
Journal Article